Based on recent data, Immunic, Inc. (IMUX) shows an Average True Range (ATR) of 0.09 and an Enterprise Value of 66.17M. Its average trading volume over the past 3 months is 264.35K, indicating liquidity. These fundamental metrics provide insight into IMUX's underlying financial health and market activity.
| ATR | 0.09 |
| Enterprise Value | 66.17M |
| Avg Vol (3 Months) | 264.35K |
| Avg Vol (10 Days) | 165K |
Immunic, Inc. (IMUX) technical indicators as of July 14, 2026: the SMA 20 is 20.43%, SMA 50 at 38.27%, and SMA 200 at 19.33%. The RSI 14 value is 64.8, suggesting its current momentum. These technical analysis signals help assess IMUX's price trends and potential future movements.
| SMA 20 | 20.43% |
| SMA 50 | 38.27% |
| SMA 200 | 19.33% |
| RSI 14 | 64.8 |
Immunic, Inc. (IMUX) stock performance overview as of July 14, 2026: The 52-week high is $15.84 (currently -29.8% below), and the 52-week low is $5.062 (currently 87.22% above). Over the past year, IMUX's performance is -34.63%, compared to the S&P 500's 5.51% change.
| 52-Week High | 15.84 |
| 52-Week High Chg | -29.80% |
| 52-Week Low | 5.062 |
| 52-Week Low Chg | +87.22% |
| S&P 500 52-Week Chg | 5.51% |
According to market data, Immunic, Inc. (IMUX) stock's recent performance metrics show that over the last month, IMUX is 11.16%, with a Year-to-Date (YTD) performance of 20.8%. Over the past year, the stock has seen a -34.63% change. These figures summarize IMUX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 15.68 | 15.84 | 15.84 | 15.84 | 15.84 | 15.84 |
| Low | 14.13 | 11.55 | 8.5 | 5.062 | 5.062 | 5.372 |
| Performance | -2.54% | +11.16% | -19.44% | -30.80% | -34.63% | +20.80% |
According to current financial data, IMUX stock's P/E (TTM) ratio is -2.46, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for IMUX, including P/S (N/A), P/B (2.94), and P/FCF (-1.79), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IMUX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.46 | -1.22 | -194.02 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 466.98 | 5.98 |
| P/B (TTM) | 2.94 | 0.87 | 11.17 | 5.29 |
| P/FCF (TTM) | -1.79 | -3.97 | -589.88 | 29.92 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep